Executive Briefing Series (formerly The Food & Drug Letter)
Oct. 5, 2012
FDA Offers Final Guidance on Labels, Drug Name Placement in Ads
A final FDA guidance addressing different advertising mediums, including TV and the web, will help drugmakers determine when and how the active ingredient, or established name, of a drug should accompany the brand name.
This article is viewable by subscribers only. To view this article, please select an option below.